Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Li, Bei Xu ^a   Zhang, Ming Chang ^a   Luo, Cheng Liang ^a   Yang, Peng ^a   Li, Hui ^a   Xu, Hong Mei ^a   Xu, Hong Fei ^a   Shen, Yi Wen ^a   Xue, Ai Min ^a   Zhao, Zi Qin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

invasion; JMJD2A; migration; proliferation; transfection

Indexed keywords

HISTONE DEMETHYLASE; JMJD2A PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; KDM4A PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SYNTHESIS; WESTERN BLOTTING; BREAST TUMOR; CELL CYCLE; CELL MOTION; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 80053441658     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-90     Document Type: Article

References (32)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin CA Cancer J Clin 2011 61 69 90
2. A brief history of RNAi: the silence of the genes. Sen GL, Blau HM, FASEB J 2006 20 1293 1299 10.1096/fj.06-6014rev 16816104 (Pubitemid 44943837)
3. Identification and characterization of JMJD2 family genes in silico. Katoh M, Katoh M, Int J Oncol 2004 24 1623 1628 15138608
4. Histone lysine demethylases and their impact on epigenetics. Trojer P, Reinberg D, Cell 2006 125 213 217 10.1016/j.cell.2006.04.003 16630806
5. Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M, Shi Y, Cell 2006 125 467 481 10.1016/j.cell.2006.03.028 16603238
6. Developmental roles of the histone lysine demethylases. Nottke A, Colaiácovo MP, Shi Y, Development 2009 136 879 889 10.1242/dev.020966 19234061
7. Functional Characterization of JMJD2A, a Histone Deacetylase- and Retinoblastoma-binding Protein. Gray SG, Iglesias AH, Lizcano F, Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW, Kokkotou E, Dangond F, J Biol Chem 2005 280 28507 28518 10.1074/jbc.M413687200 15927959 (Pubitemid 41105751)
8. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Shin S, Janknecht R, Biochem Biophys Res Commun 2007 359 742 746 10.1016/j.bbrc.2007.05.179 17555712 (Pubitemid 46901127)
9. p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Zhang XD, Wang Y, Wang Y, Zhang X, Han R, Wu JC, Liang ZQ, Gu ZL, Han F, Fukunaga K, Qin ZH, Autophagy 2009 5 339 350 10.4161/auto.5.3.8174 19305162
10. Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice. Luo CL, Li BX, Li QQ, Chen XP, Sun YX, Bao HJ, Dai DK, Shen YW, Xu HF, Ni H, Wan L, Qin ZH, Tao LY, Zhao ZQ, Neuroscience 2011 184 54 63 21463664
11. Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro. Dai HY, Liu L, Qin SK, He XM, Li SY, Biomed Pharmacother 2011 65 137 141 10.1016/j.biopha.2010.12.001 21612887
12. The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma. Li L, Zhang C, Li X, Lu S, Zhou Y, J Exp Clin Cancer Res 2010 29 133 10.1186/1756-9966-29-133 20937111
13. The epigenetics of breast cancer. Jovanovic J, Rønneberg JA, Tost J, Kristensen V, Mol Oncol 2010 4 242 254 10.1016/j.molonc.2010.04.002 20627830
14. The diverse functions of histone lysine methylation. Martin C, Zhang Y, Nat Rev Mol Cell Biol 2005 6 838 849 10.1038/nrm1761 16261189 (Pubitemid 41568733)
15. Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Müller-Tidow C, Klein HU, Hascher A, Isken F, Tickenbrock L, Thoennissen N, Agrawal-Singh S, Tschanter P, Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, zur Stadt U, Koschmieder S, Seidl M, Müller FU, Schmitz W, Schlenke P, McClelland M, Berdel WE, Dugas M, Serve H, Study Alliance Leukemia, Blood 2010 116 3564 3571 10.1182/blood-2009-09-240978 20498303
16. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Cloos PA, Christensen J, Agger K, Helin K, Genes Dev 2008 22 1115 1140 10.1101/gad.1652908 18451103 (Pubitemid 351656572)
17. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schöfer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, Jenuwein T, Cell 2001 107 323 337 10.1016/S0092-8674(01)00542-6 11701123 (Pubitemid 33049976)
18. Oncogene-induced senescence as an initial barrier in lymphoma development. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T, Schmitt CA, Nature 2005 436 660 665 10.1038/nature03841 16079837 (Pubitemid 41117262)
19. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of higher eukaryote. Schübeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, Gottschling DE, O'Neill LP, Turner BM, Delrow J, Bell SP, Groudine M, Genes Dev 2004 18 1263 1271 10.1101/gad.1198204 15175259 (Pubitemid 38720594)
20. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Shilatifard A, Annu Rev Biochem 2006 75 243 269 10.1146/annurev.biochem.75.103004.142422 16756492 (Pubitemid 44118033)
21. Covalent modifications of histones during mitosis and meiosis. Xu D, Bai J, Duan Q, Costa M, Dai W, Cell Cycle 2009 8 3688 3694 10.4161/cc.8.22.9908 19855177
22. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE, Nature 2007 448 553 560 10.1038/nature06008 17603471 (Pubitemid 47206934)
23. High-resolution profiling of histone methylations in the human genome. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K, Cell 2007 129 823 837 10.1016/j.cell.2007.05.009 17512414 (Pubitemid 46802390)
24. Histone modification patterns associated with the human X chromosome. Brinkman AB, Roelofsen T, Pennings SW, Martens JH, Jenuwein T, Stunnenberg HG, EMBO Rep 2006 7 628 634 16648823 (Pubitemid 43827331)
25. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Vakoc CR, Mandat SA, Olenchock BA, Blobel GA, Mol Cell 2005 19 381 391 10.1016/j.molcel.2005.06.011 16061184 (Pubitemid 41074893)
26. Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding. Gomes NP, Espinosa JM, Genes Dev 2010 24 1022 1034 10.1101/gad.1881010 20478995
27. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. Kawazu M, Saso K, Tong KI, McQuire T, Goto K, Son DO, Wakeham A, Miyagishi M, Mak TW, Okada H, PLoS One 2011 6 17830 10.1371/journal.pone.0017830 21445275
28. Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. Gray SG, Iglesias AH, Lizcano F, Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW, Kokkotou E, Dangond F, J Biol Chem 2005 280 28507 28518 10.1074/jbc.M413687200 15927959 (Pubitemid 41105751)
29. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro. Takaki T, Fukasawa K, Suzuki-Takahashi I, Hirai H, Biochem Biophys Res Commun 2004 316 252 255 10.1016/j.bbrc.2004.02.044 15003538 (Pubitemid 38299153)
30. RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Lai A, Kennedy BK, Barbie DA, Bertos NR, Yang XJ, Theberge MC, Tsai SC, Seto E, Zhang Y, Kuzmichev A, Lane WS, Reinberg D, Harlow E, Branton PE, Mol Cell Biol 2001 21 2918 2932 10.1128/MCB.21.8.2918-2932.2001 11283269 (Pubitemid 32244934)
31. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M, Mills GB, Bast RC Jr, Proc Natl Acad Sci USA 1999 96 214 219 10.1073/pnas.96.1.214 9874798 (Pubitemid 29036079)
32. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y, Oncogene 2006 25 230 239 16158053 (Pubitemid 43083684)